The US pharmaceutical analytical testing outsourcing market is estimated to grow at a CAGR of around 8.1% during the forecast period. The market is mainly driven due to the presence of major global players in the country, significant investment in the pharmaceutical sector, considerable growth in pharmaceutical outsourcing services in the country. Moreover, the significant presence of regulations and standards related to drug safety projected to encourage the demand for analytical outsourcing services in the country.
The US pharmaceutical analytical testing outsourcing market is classified on the basis of product type and application. Based on the product type, the market is further classified into API, raw materials, and finished products. The API segment is projected to have considerable growth during the forecast period. Based on the application, the US pharmaceutical analytical testing outsourcing market is further segmented into Bioanalytical services, stability testing, drug substance, method development & validation, and others. Among application, the bioanalytical services segment projected to hold considerable market share in the US pharmaceutical analytical testing outsourcing market.
Furthermore, the US pharmaceutical analytical testing outsourcing market is characterized by the presence of several market players that are catering to a wide range of customers across the globe. Some of the key players in the market include Boston Analytical Inc., Bioanalytical Systems, Inc., Charles River Laboratories International, Inc., CMIC, Inc, Cambrex Corp., Covance Inc., Dalton Pharma Services, and others. These players adopt various strategies to remain competitive in the market and gain a competitive advantage over other players operating in the market. Mergers and acquisitions, product launch, and partnerships and collaborations, and geographical expansion are some of the major activities adopted by the market players.
Research Methodology
The market study of the US pharmaceutical analytical testing outsourcing market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for pharmaceutical analytical testing outsourcing market players, pharmaceutical manufacturers, contract manufacturers, distributors & traders, industry associates & experts, government organizations, regulatory bodies, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the US Pharmaceutical Analytical Testing Outsourcing Industry
• Recovery Scenario of the US Pharmaceutical Analytical Testing Outsourcing Industry
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. US Pharmaceutical Analytical Testing Outsourcing Market by Product type
5.1.1. API
5.1.2. Raw Materials
5.1.3. Finished products
5.2. US Pharmaceutical Analytical Testing Outsourcing Market by Services
5.2.1. Bioanalytical services
5.2.2. Stability testing
5.2.3. Drug substance
5.2.4. Method development & Validation
5.2.5. Others (Quality Testing)
6. Company Profiles
6.1. Boston Analytical Inc.
6.2. Bioanalytical Systems, Inc.
6.3. Charles River Laboratories International, Inc.
6.4. CMIC, Inc.
6.5. Cambrex Corp.
6.6. Covance Inc.
6.7. Dalton Pharma Services
6.8. KCAS Bioanalytical Services
6.9. NorthEastBioAnalytical Laboratories LLC.
6.10. Pace Analytical Services, LLC
6.11. Pharmaceutical Product Development, LLC
6.12. Toxikon Corp.
6.13. VxP Pharma, Inc.
6.14. West Pharmaceutical Services, Inc.
1. US PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
2. US PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027($ MILLION)
1. IMPACT OF COVID-19 ON US PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, 2020-2027 (% MILLION)
2. IMPACT OF COVID-19 ON US PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET BY SEGMENT, 2020-2027 (% MILLION)
3. RECOVERY OF US PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, 2020-2027 (%)
4. US PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE BYPRODUCT TYPE, 2020 VS 2027 (%)
5. US PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY SERVICES, 2020 VS 2027 (%)
6. US PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027($ MILLION)